Top Markets
Coin of the day
AmCad BioMed Corporation AmCad BioMed Corporation

AmCad BioMed Corporation

4188
Rang in Aktien #29617
AmCad BioMed Corporation develops computer-aided detection and diagnosis (CAD)... AmCad BioMed Corporation develops computer-aided detection and diagnosis (CAD) software devices primarily in Taiwan. It offers products for early detection and diagnosis of various diseases. The company's products include AmCAD-UT Detection, a CAD device for ultrasound images of thyroid nodules; and AmCAD-UO for detection of obstructive sleep apnea on awake patients. It also developing AmCAD-US, a software device for visualizing and quantifying statistical distributions of backscattered signals echoed by tissue compositions in the body from FDA-cleared ultrasound systems; and AmCAD-UB, an AI Solution for Breast Lesion Detection. The company was incorporated in 2008 and is based in Taipei City, Taiwan.
Aktienkurs
$0.32117018
Marktkapitalisierung
$20.34M
Veränderung (1 Tag)
-0.98%
Veränderung (1 Jahr)
-34.41%
Land
TW
Handel AmCad BioMed Corporation (4188)

Kategorie

Kursverlauf für AmCad BioMed Corporation (4188)
Höchster Schlusskurs: $0.32 am 2026-08-01

Niedrigster Schlusskurs: $1.94 am 2013-12-01
Kursverlauf der Aktie von AmCad BioMed Corporation von 2013 bis 2026
Jährliche Kursentwicklung
Jahr Leistung
2026 (TTM) -10.50%
2025 -28.92%
2024 -24.36%
2023 70.73%
2022 -22.51%
2021 -2.35%
2020 -13.23%
2019 -11.66%
2018 -3.70%
2017 -0.80%
2016 6.59%
2015 -27.35%
2014 -37.02%
2013 0.00%
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Aktienkurs Veränderung 1J% Land
$215.45 -21.94%
DE
$149.99 7.71%
CA
$197.00 -19.92%
US
$74.93 -21.40%
US
$120.14 -32.26%
US